M. R., P. H. P., and M. H. R., “A prospective analysis of the cost-effectiveness of alfuzosin, tamsulosin and silodosin for 12 weeks in benign prostatic hyperplasia”, Int J Basic Clin Pharmacol, vol. 5, no. 6, pp. 2481–2487, Dec. 2016.